60 The Cutting Edge of Infection Prevention: The Top Four Submitted Scientific Papers of the 2010 Decennial

Saturday, March 20, 2010: 8:30 AM-9:30 AM
Centennial Ballroom (Hyatt Regency Atlanta)
Type: Oral
Summary: Four abstracts were selected from amongst the 913 submissions for presentation at the this special plenary session. The abstracts were chosen to represent the strength and breath of research in infection prevention that is being presented at this conference.
Learning Objectives: Not Applicable
Moderators:
Mary K. Hayden, MD and Arjun Srinivasan, MD
8:30 AM
384
A Cluster-Randomized, Cross-over Study of the Efficacy of Plain Soap and Water Versus Alcohol-Based rub for Surgical Hand Preparation
Peter Nthumba, Africa Inland Church Kijabe Hospital; Edita Stepita-Poenaru, Africa Inland Church Kijabe Hospital; Dan Poenaru, Africa Inland Church Kijabe Hospital; Peter Bird, Africa Inland Church Kijabe Hospital; Benedetta Allegranzi, WHO; Didier Pittet, Geneva University Hospitals; Stephan Harbarth, MD, Geneva University Hospitals
8:45 AM
385
Implementation of a Successful Seasonal Influenza Vaccine Strategy in a Large Healthcare System
Scott B. Cormier, NREMT-P, IMRA-T, Hospital Corporation of America (HCA); Edward J. Septimus, MD, FACP, FIDSA, Hospital Corporation of America (HCA); Julia A. Moody, MS, SM, (ASCP), Hospital Corporation of America (HCA); Jason D. Hickok, MBA, RN, Hospital Corporation of America (HCA); Jonathan B. Perlin, MD, PhD, MSHA, Hospital Corporation of America (HCA)
9:00 AM
386
The Impact of Hospital-Onset Healthcare Facility Associated (HO-HCFA) Clostridium Difficile Infection (CDI) in Community Hospitals: Surpassing Methicillin-Resistant Staphylococcus aureus (MRSA) as the New Superbug
Becky A. Miller, MD, Duke University Medical Center; Luke F. Chen, MBBS, FRACP, Duke University Medical Center; Daniel J. Sexton, MD, FACP, Duke University Medical Center; Deverick J. Anderson, MD, MPH, Duke University Medical Center
9:15 AM
387
Central Line Bundle Implementation and Impact on Infection Rates in US Intensive Care Units (ICU)
E. Yoko Furuya, MD, MS, Columbia University; Andrew Dick, PhD, RAND Corporation; Eli N. Perencevich, MD, MS, Department of Epidemiology and Preventive Medicine, University of Maryland School of Medicine; Monika Pogorzelska, MPH, Columbia University; Donald Goldmann, MD, Institute for Healthcare Improvement; Patricia Stone, PhD, FAAN, Columbia University